Keywords: myotrophin, nda, cephalon, chiron, agreed, submit, new

Myotrophin NDA

Article | 22 April 1996

Print This

Cephalon and Chiron have agreed to submit a New Drug Application in the USA for their amyotrophic lateral sclerosis treatment, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in